PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Proguanil hydrochloride with atovaquone
Presentation Product Chemical substance Chapter Items dispensed
Proguanil 100mg / Atovaquone 250mg tablets
0504010U0AAAAAA
Proguanil hydrochloride/atovaquone Proguanil hydrochloride with atovaquone Infections 96
Malarone 250mg/100mg tablets
0504010U0BBAAAA
Malarone Proguanil hydrochloride with atovaquone Infections 58
Malarone Paediatric 62.5mg/25mg tablets
0504010U0BBABAB
Malarone Proguanil hydrochloride with atovaquone Infections 29
Proguanil 25mg / Atovaquone 62.5mg tablets
0504010U0AAABAB
Proguanil hydrochloride/atovaquone Proguanil hydrochloride with atovaquone Infections 29
Maloff Protect 250mg/100mg tablets
0504010U0BEAAAA
Maloff Protect Proguanil hydrochloride with atovaquone Infections 1
Mafamoz 250mg/100mg tablets
0504010U0BDABAA
Mafamoz Proguanil hydrochloride with atovaquone Infections No data available
Mafamoz 62.5mg/25mg tablets
0504010U0BDAAAB
Mafamoz Proguanil hydrochloride with atovaquone Infections No data available
Reprapog 250mg/100mg tablets
0504010U0BCABAA
Reprapog Proguanil hydrochloride with atovaquone Infections No data available
Reprapog 62.5mg/25mg tablets
0504010U0BCAAAB
Reprapog Proguanil hydrochloride with atovaquone Infections No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.